Mary De Vera

Mary De Vera is an Associate Professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia and a Senior Scientist at Arthritis Research Canada. Her research focuses on medication adherence, patient outcomes in arthritis, reproductive health in cancer survivors, and eHealth technologies to improve care delivery.

• BSc in Biochemistry, UBC
• MSc and PhD in Healthcare and Epidemiology, UBC School of Population and Public Health

Dr. De Vera employs population-based administrative databases across Canada (BC, Quebec) to study medication utilization and health outcomes. Recent work addresses eHealth interventions, equity in clinical trials, and intersectional impacts of cost-related non-adherence on mental health.

Her 15 most recent publications span topics including oral anticoagulant adherence, reproductive outcomes in autoimmune diseases, and COPD medication management, with methodological strengths in causal inference, latent class analysis, and patient engagement frameworks.

• Killam Award for Excellence in Mentoring (2021)
• Women’s Health Research Institute Mentorship Award (2021)
• Tier 2 Canada Research Chair (2017-2022)
• Michael Smith Foundation Scholar Award (2014-2021)

Dr. De Vera supervises students like Megan Thomas (PhD in Pharmaceutical Sciences) and leads grants exceeding $1.5 million, including projects on reproductive health outcomes in young cancer patients (CIHR Project Grant, $313,649) and pregnancy safety of arthritis medications (The Arthritis Society, $421,128).